Guideline on the Use of Iodinated Contrast Media in Patients With Kidney Disease 2018.

[1]  K. Iseki,et al.  The Japanese clinical practice guideline for acute kidney injury 2016 , 2018, Clinical and Experimental Nephrology.

[2]  Long Jiang Zhang,et al.  Acute kidney injury in patients with nephrotic syndrome undergoing contrast-enhanced CT for suspected venous thromboembolism: a propensity score-matched retrospective cohort study , 2018, European Radiology.

[3]  Y. Yamashita,et al.  Dual-layer DECT for multiphasic hepatic CT with 50 percent iodine load: a matched-pair comparison with a 120 kVp protocol , 2018, European Radiology.

[4]  G. Cigliana,et al.  Iodixanol versus iopromide in cancer patients: Evidence from a randomized clinical trial , 2018, Journal of cellular physiology.

[5]  G. Bongartz,et al.  Post-contrast acute kidney injury – Part 1: Definition, clinical features, incidence, role of contrast medium and risk factors , 2018, European Radiology.

[6]  G. Bongartz,et al.  Post-contrast acute kidney injury. Part 2: risk stratification, role of hydration and other prophylactic measures, patients taking metformin and chronic dialysis patients , 2018, European Radiology.

[7]  Deepak L. Bhatt,et al.  Outcomes after Angiography with Sodium Bicarbonate and Acetylcysteine , 2017, The New England journal of medicine.

[8]  T. Merchant,et al.  Quantifying potential reduction in contrast dose with monoenergetic images synthesized from dual-layer detector spectral CT. , 2017, The British journal of radiology.

[9]  D. Kallmes,et al.  Is Intravenous Administration of Iodixanol Associated with Increased Risk of Acute Kidney Injury, Dialysis, or Mortality? A Propensity Score-adjusted Study. , 2017, Radiology.

[10]  N. Pannu,et al.  Risk Prediction Models for Contrast-Induced Acute Kidney Injury Accompanying Cardiac Catheterization: Systematic Review and Meta-analysis. , 2017, The Canadian journal of cardiology.

[11]  S. de Servi,et al.  Acute Kidney Injury After Radial or Femoral Access for Invasive Acute Coronary Syndrome Management: AKI-MATRIX. , 2017, Journal of the American College of Cardiology.

[12]  Y. Tsushima,et al.  Contrast-induced nephropathy (CIN) of patients with renal dysfunction in CT examination , 2017, Japanese Journal of Radiology.

[13]  R. Bellomo,et al.  Acute kidney injury in the ICU: from injury to recovery: reports from the 5th Paris International Conference , 2017, Annals of Intensive Care.

[14]  Elliot K Fishman,et al.  Risk of Acute Kidney Injury After Intravenous Contrast Media Administration , 2017, Annals of emergency medicine.

[15]  A. Shahidzadeh,et al.  Strategies Preventing Contrast-Induced Nephropathy After Coronary Angiography: A Comprehensive Meta-Analysis and Systematic Review of 125 Randomized Controlled Trials , 2017, Angiology.

[16]  U. Schoepf,et al.  Low contrast medium-volume third-generation dual-source computed tomography angiography for transcatheter aortic valve replacement planning , 2017, European Radiology.

[17]  B. Kissela,et al.  Association Between Acute Kidney Disease and Intravenous Dye Administration in Patients With Acute Stroke: A Population-Based Study , 2017, Stroke.

[18]  J. Wildberger,et al.  Prophylactic hydration to protect renal function from intravascular iodinated contrast material in patients at high risk of contrast-induced nephropathy (AMACING): a prospective, randomised, phase 3, controlled, open-label, non-inferiority trial , 2017, The Lancet.

[19]  J. Messenger,et al.  Longitudinal Risk of Adverse Events in Patients With Acute Kidney Injury After Percutaneous Coronary Intervention: Insights From the National Cardiovascular Data Registry , 2017, Circulation. Cardiovascular interventions.

[20]  G. Pedrazzini,et al.  Prevention of Contrast-Induced Acute Kidney Injury by Furosemide With Matched Hydration in Patients Undergoing Interventional Procedures A , 2017 .

[21]  K. Kashani,et al.  Contrast-induced acute kidney injury in kidney transplant recipients: A systematic review and meta-analysis , 2017, World journal of transplantation.

[22]  M. van Meurs,et al.  Incidence, timing and outcome of AKI in critically ill patients varies with the definition used and the addition of urine output criteria , 2017, BMC Nephrology.

[23]  D. Kallmes,et al.  Post-contrast acute kidney injury in intensive care unit patients: a propensity score-adjusted study , 2017, Intensive Care Medicine.

[24]  Y. Yamashita,et al.  Using 80 kVp on a 320-row scanner for hepatic multiphasic CT reduces the contrast dose by 50 % in patients at risk for contrast-induced nephropathy , 2017, European Radiology.

[25]  T. Ashikaga,et al.  Sodium Bicarbonate-Ascorbic Acid Combination for Prevention of Contrast-Induced Nephropathy in Chronic Kidney Disease Patients Undergoing Catheterization. , 2017, Circulation journal : official journal of the Japanese Circulation Society.

[26]  T. Akasaka,et al.  Association of contrast-induced nephropathy with risk of adverse clinical outcomes in patients with cardiac catheterization: From the CINC-J study. , 2017, International journal of cardiology.

[27]  D. Kallmes,et al.  Acute Kidney Injury After Intravenous Versus Intra-Arterial Contrast Material Administration in a Paired Cohort , 2016, Investigative radiology.

[28]  J. Leipsic,et al.  SCCT guidelines for the performance and acquisition of coronary computed tomographic angiography: A report of the society of Cardiovascular Computed Tomography Guidelines Committee: Endorsed by the North American Society for Cardiovascular Imaging (NASCI). , 2016, Journal of cardiovascular computed tomography.

[29]  R. Roussel,et al.  Metformin and contrast-induced acute kidney injury in diabetic patients treated with primary percutaneous coronary intervention for ST segment elevation myocardial infarction: Amulticenter study. , 2016, International journal of cardiology.

[30]  G. Gargiulo,et al.  Renal dysfunction and transcatheter aortic valve implantation outcomes , 2016, Expert review of cardiovascular therapy.

[31]  D. Sahani,et al.  Prospective Comparison of Reduced-Iodine-Dose Virtual Monochromatic Imaging Dataset From Dual-Energy CT Angiography With Standard-Iodine-Dose Single-Energy CT Angiography for Abdominal Aortic Aneurysm. , 2016, AJR. American journal of roentgenology.

[32]  M. Wintermark,et al.  Safety of Computed Tomographic Angiography in the Evaluation of Patients With Acute Stroke: A Single-Center Experience , 2016, Stroke.

[33]  M. Heller,et al.  Contrast CT Scans in the Emergency Department Do Not Increase Risk of Adverse Renal Outcomes , 2016, The western journal of emergency medicine.

[34]  Shi-sheng Zhou,et al.  Effect of Angiotensin-Converting Enzyme Inhibitors in Contrast-Induced Nephropathy: A Meta-Analysis , 2016, Nephron.

[35]  Keith T. Chan,et al.  Dual-energy CT Aortography with 50% Reduced Iodine Dose Versus Single-energy CT Aortography with Standard Iodine Dose. , 2016, Academic radiology.

[36]  H. Miyata,et al.  Performance and Validation of the U.S. NCDR Acute Kidney Injury Prediction Model in Japan. , 2016, Journal of the American College of Cardiology.

[37]  Sung-Yuan Hu,et al.  Contrast Medium Exposure During Computed Tomography and Risk of Development of End-Stage Renal Disease in Patients With Chronic Kidney Disease , 2016, Medicine.

[38]  Yanbo Wang,et al.  Effect of rhBNP on renal function in STEMI-HF patients with mild renal insufficiency undergoing primary PCI , 2016, Heart and Vessels.

[39]  Y. Yamashita,et al.  Impact of Knowledge-Based Iterative Model Reconstruction in Abdominal Dynamic CT With Low Tube Voltage and Low Contrast Dose. , 2016, AJR. American journal of roentgenology.

[40]  Kyung Soo Lim,et al.  Contrast-induced nephropathy in patients with active cancer undergoing contrast-enhanced computed tomography , 2016, Supportive Care in Cancer.

[41]  U. Schoepf,et al.  Automated tube voltage selection for radiation dose and contrast medium reduction at coronary CT angiography using 3rd generation dual-source CT , 2016, European Radiology.

[42]  Renee F Wilson,et al.  Comparative Effect of Contrast Media Type on the Incidence of Contrast-Induced Nephropathy , 2016, Annals of Internal Medicine.

[43]  Yongjun Li,et al.  Recombinant Brain Natriuretic Peptide for the Prevention of Contrast-Induced Nephropathy in Patients with Chronic Kidney Disease Undergoing Nonemergent Percutaneous Coronary Intervention or Coronary Angiography: A Randomized Controlled Trial , 2016, BioMed research international.

[44]  Renee F Wilson,et al.  Effectiveness of Prevention Strategies for Contrast-Induced Nephropathy , 2016, Annals of Internal Medicine.

[45]  K. Poh,et al.  Comparison of combination therapy of high-dose oral N-acetylcysteine and intravenous sodium bicarbonate hydration with individual therapies in the reduction of Contrast-induced Nephropathy during Cardiac Catheterisation and Percutaneous Coronary Intervention (CONTRAST): A multi-centre, randomised, c , 2015, International journal of cardiology.

[46]  Michael E. Matheny,et al.  Acute Kidney Injury Risk Prediction in Patients Undergoing Coronary Angiography in a National Veterans Health Administration Cohort With External Validation , 2015, Journal of the American Heart Association.

[47]  K. Adambounou,et al.  Intravenous Contrast Medium Administration for Computed Tomography Scan in Emergency: A Possible Cause of Contrast-Induced Nephropathy , 2015, Radiology research and practice.

[48]  Samir F. Abboud,et al.  CT of the Abdomen with Reduced Tube Voltage in Adults: A Practical Approach. , 2015, Radiographics : a review publication of the Radiological Society of North America, Inc.

[49]  Z. Harel,et al.  Risk prediction models for contrast induced nephropathy: systematic review , 2015, BMJ : British Medical Journal.

[50]  G. Stone,et al.  Impact of Contrast-Induced Acute Kidney Injury After Percutaneous Coronary Intervention on Short- and Long-Term Outcomes: Pooled Analysis From the HORIZONS-AMI and ACUITY Trials , 2015, Circulation. Cardiovascular interventions.

[51]  D. Kallmes,et al.  Risk of Acute Kidney Injury, Dialysis, and Mortality in Patients With Chronic Kidney Disease After Intravenous Contrast Material Exposure. , 2015, Mayo Clinic proceedings.

[52]  S. Mehta,et al.  Effects of withdrawing vs continuing renin-angiotensin blockers on incidence of acute kidney injury in patients with renal insufficiency undergoing cardiac catheterization: Results from the Angiotensin Converting Enzyme Inhibitor/Angiotensin Receptor Blocker and Contrast Induced Nephropathy in Patie , 2015, American heart journal.

[53]  C. Pepine,et al.  Acute Kidney Injury after Transcatheter Aortic Valve Replacement , 2015, American Journal of Nephrology.

[54]  K. Sun,et al.  Effect of reduced x-ray tube voltage, low iodine concentration contrast medium, and sinogram-affirmed iterative reconstruction on image quality and radiation dose at coronary CT angiography: results of the prospective multicenter REALISE trial. , 2015, Journal of cardiovascular computed tomography.

[55]  M. Velázquez,et al.  Role of hydration in contrast-induced nephropathy in patients who underwent primary percutaneous coronary intervention. , 2015, The American journal of cardiology.

[56]  O. Baydar,et al.  Impact of Rosuvastatin on contrast-induced acute kidney injury in patients at high risk for nephropathy undergoing elective angiography. , 2015, The American journal of cardiology.

[57]  Yong Peng,et al.  Impact of Renal Dysfunction on Mid-Term Outcome after Transcatheter Aortic Valve Implantation: A Systematic Review and Meta-Analysis , 2015, PloS one.

[58]  Yi Li,et al.  Rosuvastatin attenuated contrast-induced nephropathy in diabetes patients with renal dysfunction. , 2015, International journal of clinical and experimental medicine.

[59]  A. Sannino,et al.  Moderate and Severe Preoperative Chronic Kidney Disease Worsen Clinical Outcomes After Transcatheter Aortic Valve Implantation: Meta-Analysis of 4992 Patients , 2015, Circulation. Cardiovascular interventions.

[60]  Jeong Hoon Yang,et al.  Predictors of outcomes of contrast-induced acute kidney injury after percutaneous coronary intervention in patients with chronic kidney disease. , 2014, The American journal of cardiology.

[61]  Yongjun Li,et al.  Brain natriuretic peptide for prevention of contrast-induced nephropathy after percutaneous coronary intervention or coronary angiography. , 2014, The Canadian journal of cardiology.

[62]  Michael E. Matheny,et al.  Validated Contemporary Risk Model of Acute Kidney Injury in Patients Undergoing Percutaneous Coronary Interventions: Insights From the National Cardiovascular Data Registry Cath‐PCI Registry , 2014, Journal of the American Heart Association.

[63]  Hyo‐Soo Kim,et al.  The Impact of Renin-Angiotensin-Aldosterone System Blockade on Contrast-Induced Nephropathy: A Meta-Analysis of 12 Studies with 4,493 Patients , 2014, Cardiology.

[64]  N. Çam,et al.  Efficacy of Oral Hydration in the Prevention of Contrast-Induced Acute Kidney Injury in Patients Undergoing Coronary Angiography or Intervention , 2014, Nephron Clinical Practice.

[65]  H. Akbari,et al.  Comparison between three supportive treatments for prevention of contrast-induced nephropathy in high-risk patients undergoing coronary angiography. , 2014, Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia.

[66]  D. Dvir,et al.  Advanced chronic kidney disease in patients undergoing transcatheter aortic valve implantation: insights on clinical outcomes and prognostic markers from a large cohort of patients. , 2014, European heart journal.

[67]  M. Reiser,et al.  Contrast-induced acute kidney injury after computed tomography prior to transcatheter aortic valve implantation. , 2014, Clinical radiology.

[68]  R. Hartman,et al.  Intravenous contrast material exposure is not an independent risk factor for dialysis or mortality. , 2014, Radiology.

[69]  Eun Mi Lee,et al.  Effect of High Dose Rosuvastatin Loading before Percutaneous Coronary Intervention on Contrast-Induced Nephropathy , 2014, Korean circulation journal.

[70]  H. Sanei,et al.  Short term high dose atorvastatin for the prevention of contrast-induced nephropathy in patients undergoing computed tomography angiography , 2014, ARYA atherosclerosis.

[71]  Takeshi Kimura,et al.  Relation of contrast-induced nephropathy to long-term mortality after percutaneous coronary intervention. , 2014, The American journal of cardiology.

[72]  Wei Ren,et al.  Different interventions in preventing contrast-induced nephropathy after percutaneous coronary intervention , 2014, International Urology and Nephrology.

[73]  H. Nishina,et al.  Association of contrast-induced acute kidney injury with long-term cardiovascular events in acute coronary syndrome patients with chronic kidney disease undergoing emergent percutaneous coronary intervention. , 2014, International journal of cardiology.

[74]  E. Dervişoğlu,et al.  Comparison of short-term infusion regimens of N-acetylcysteine plus intravenous fluids, sodium bicarbonate plus intravenous fluids, and intravenous fluids alone for prevention of contrast-induced nephropathy in the emergency department. , 2014, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[75]  A. Colombo,et al.  Acute kidney injury after transcatheter aortic valve implantation with self-expanding CoreValve prosthesis: results from a large multicentre Italian research project. , 2014, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[76]  K. Veien,et al.  Prevention of Contrast-Induced Nephropathy With N-Acetylcysteine or Sodium Bicarbonate in Patients With ST-Segment–Myocardial Infarction: A Prospective, Randomized, Open-Labeled Trial , 2014, Circulation. Cardiovascular interventions.

[77]  H. Gurm,et al.  Risk of Acute Kidney Injury After Percutaneous Coronary Interventions Using Radial Versus Femoral Vascular Access: Insights From the Blue Cross Blue Shield of Michigan Cardiovascular Consortium , 2014, Circulation. Cardiovascular interventions.

[78]  J. Ellis,et al.  The challenges in assessing contrast-induced nephropathy: where are we now? , 2014, AJR. American journal of roentgenology.

[79]  E. Romagnoli,et al.  Nephropathy after administration of iso-osmolar and low-osmolar contrast media: evidence from a network meta-analysis. , 2014, International journal of cardiology.

[80]  M. Zheng,et al.  Low concentration contrast medium for dual-source computed tomography coronary angiography by a combination of iterative reconstruction and low-tube-voltage technique: feasibility study. , 2014, European journal of radiology.

[81]  S. Chu,et al.  Low-tube-voltage (80 kVp) CT aortography using 320-row volume CT with adaptive iterative reconstruction: lower contrast medium and radiation dose , 2014, European Radiology.

[82]  D. Kallmes,et al.  Risk of intravenous contrast material-mediated acute kidney injury: a propensity score-matched study stratified by baseline-estimated glomerular filtration rate. , 2014, Radiology.

[83]  R. Mehran,et al.  Short-term rosuvastatin therapy for prevention of contrast-induced acute kidney injury in patients with diabetes and chronic kidney disease. , 2014, Journal of the American College of Cardiology.

[84]  M. Valgimigli,et al.  Acute kidney injury after primary angioplasty: effect of different hydration treatments , 2014, Journal of cardiovascular medicine.

[85]  J. Kellum,et al.  N-acetylcysteine plus intravenous fluids versus intravenous fluids alone to prevent contrast-induced nephropathy in emergency computed tomography. , 2013, Annals of emergency medicine.

[86]  V. Novack,et al.  Renal safety and angiotensin II blockade medications in patients undergoing non-emergent coronary angiography: a randomized controlled study. , 2013, The Israel Medical Association journal : IMAJ.

[87]  J. Dubois-Randé,et al.  Prognostic value of chronic kidney disease after transcatheter aortic valve implantation. , 2013, Journal of the American College of Cardiology.

[88]  O. Oliyarnyk,et al.  Prevention of contrast-induced nephropathy in diabetic patients with impaired renal function: a randomized, double blind trial of sodium bicarbonate versus sodium chloride-based hydration. , 2013, Diabetes research and clinical practice.

[89]  J. Ellis,et al.  Contrast material-induced nephrotoxicity and intravenous low-osmolality iodinated contrast material: risk stratification by using estimated glomerular filtration rate. , 2013, Radiology.

[90]  J. Stoker,et al.  Contrast induced nephropathy in patients undergoing intravenous (IV) contrast enhanced computed tomography (CECT) and the relationship with risk factors: a meta-analysis. , 2013, European journal of radiology.

[91]  F. Gaita,et al.  30 days and midterm outcomes of patients undergoing percutaneous replacement of aortic valve according to their renal function: a multicenter study. , 2013, International journal of cardiology.

[92]  R. Ekart,et al.  Ascorbic Acid for the Prevention of Contrast‐Induced Nephropathy After Coronary Angiography in Patients With Chronic Renal Impairment: A Randomized Controlled Trial , 2013, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

[93]  H. Baumbach,et al.  Transcatheter aortic valve replacement: does kidney function affect outcome? , 2013, The Annals of thoracic surgery.

[94]  H. Gurm,et al.  A novel tool for reliable and accurate prediction of renal complications in patients undergoing percutaneous coronary intervention. , 2013, Journal of the American College of Cardiology.

[95]  James E. Novak,et al.  Contrast-induced acute kidney injury following coronary angiography: a cohort study of hospitalized patients with or without chronic kidney disease. , 2013, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[96]  A. Boening,et al.  Usefulness of N-acetylcysteine or ascorbic acid versus placebo to prevent contrast-induced acute kidney injury in patients undergoing elective cardiac catheterization: a single-center, prospective, randomized, double-blind, placebo-controlled trial. , 2013, The Journal of invasive cardiology.

[97]  S. Saygi,et al.  N-acetylcysteine in preventing contrast-induced nephropathy assessed by cystatin C. , 2013, Cardiovascular therapeutics.

[98]  Mu‐Shun Huang,et al.  Risk factors for acute kidney injury in the elderly undergoing contrast‐enhanced computed tomography in the emergency department , 2013, Journal of the Chinese Medical Association : JCMA.

[99]  P. Serruys,et al.  Impact of preoperative chronic kidney disease on short- and long-term outcomes after transcatheter aortic valve implantation: a Pooled-RotterdAm-Milano-Toulouse In Collaboration Plus (PRAGMATIC-Plus) initiative substudy. , 2013, American heart journal.

[100]  J. Hamming,et al.  Contrast-induced acute kidney injury and clinical outcomes after intra-arterial and intravenous contrast administration: risk comparison adjusted for patient characteristics by design. , 2013, American heart journal.

[101]  J. Bida,et al.  Intravenous contrast material-induced nephropathy: causal or coincident phenomenon? , 2013, Radiology.

[102]  A. Roychoudhury,et al.  Quantitating contrast medium-induced nephropathy: controlling the controls. , 2013, Radiology.

[103]  D. Kallmes,et al.  Frequency of acute kidney injury following intravenous contrast medium administration: a systematic review and meta-analysis. , 2013, Radiology.

[104]  J. Ellis,et al.  Contrast material-induced nephrotoxicity and intravenous low-osmolality iodinated contrast material. , 2013, Radiology.

[105]  Akram Khan,et al.  Epidemiology of Acute Kidney Injury in the Intensive Care Unit , 2013, Critical care research and practice.

[106]  M. Tonelli,et al.  Contrast-Induced Acute Kidney Injury and Risk of Adverse Clinical Outcomes After Coronary Angiography: A Systematic Review and Meta-Analysis , 2013, Circulation. Cardiovascular interventions.

[107]  H. Tamim,et al.  Efficacy of ascorbic acid, N-acetylcysteine, or combination of both on top of saline hydration versus saline hydration alone on prevention of contrast-Induced nephropathy: a prospective randomized study. , 2013, Journal of interventional cardiology.

[108]  Arnold M. R. Schilham,et al.  Iterative reconstruction techniques for computed tomography Part 1: Technical principles , 2013, European Radiology.

[109]  M. Hayashi,et al.  Effects of Carperitide on Contrast-Induced Acute Kidney Injury with a Minimum Volume of Contrast in Chronic Kidney Disease Patients , 2012, Nephron Extra.

[110]  Airton O. Arruda,et al.  Hydration with sodium bicarbonate does not prevent contrast nephropathy: a multicenter clinical trial. , 2012, Arquivos brasileiros de cardiologia.

[111]  J. Ellis,et al.  Comparative investigation of i.v. iohexol and iopamidol: effect on renal function in low-risk outpatients undergoing CT. , 2012, AJR. American journal of roentgenology.

[112]  Ben He,et al.  Renal tolerability of iopromide and iodixanol in 562 renally impaired patients undergoing cardiac catheterisation: the DIRECT study. , 2012, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[113]  T. Hirai,et al.  Evaluation of deep vein thrombosis with reduced radiation and contrast material dose at computed tomography venography: clinical application of a combined iterative reconstruction and low-tube-voltage technique. , 2012, Circulation journal : official journal of the Japanese Circulation Society.

[114]  R. Sinert,et al.  Does the current definition of contrast-induced acute kidney injury reflect a true clinical entity? , 2012, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[115]  Le-Xin Wang,et al.  Comparison of oral and intravenous hydration strategies for the prevention of contrast-induced nephropathy in patients undergoing coronary angiography or angioplasty: a randomized clinical trial , 2012, Acta cardiologica.

[116]  Hui-ru Chen,et al.  PREVENTION OF CONTRAST-INDUCED NEPHROPATHY WITH ASCORBIC ACID , 2012, Heart.

[117]  P. Boekstegers,et al.  Chronic kidney disease is not associated with a higher risk for mortality or acute kidney injury in transcatheter aortic valve implantation. , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[118]  K. Miyata,et al.  Sodium bicarbonate for the prevention of contrast-induced nephropathy: the efficacy of high concentration solution. , 2012, The Journal of invasive cardiology.

[119]  Takeshi Nakaura,et al.  Low contrast agent and radiation dose protocol for hepatic dynamic CT of thin adults at 256-detector row CT: effect of low tube voltage and hybrid iterative reconstruction algorithm on image quality. , 2012, Radiology.

[120]  Xiangnan Li,et al.  Beneficial Effects of High-Dose Atorvastatin Pretreatment on Renal Function in Patients with Acute ST-Segment Elevation Myocardial Infarction Undergoing Emergency Percutaneous Coronary Intervention , 2012, Cardiology.

[121]  M. Leoncini,et al.  Persistent Renal Damage After Contrast-Induced Acute Kidney Injury: Incidence, Evolution, Risk Factors, and Prognosis , 2012, Circulation.

[122]  H. Oflaz,et al.  Intrarenal application of N-acetylcysteine for the prevention of contrast medium-induced nephropathy in primary angioplasty , 2012, Coronary artery disease.

[123]  D. Berman,et al.  Within-hospital and 30-day outcomes in 107,994 patients undergoing invasive coronary angiography with different low-osmolar iodinated contrast media. , 2012, The American journal of cardiology.

[124]  S. Kumita,et al.  Contrast-induced nephropathy in patients with renal insufficiency undergoing contrast-enhanced MDCT , 2012, European Radiology.

[125]  J. Jenkins,et al.  A randomized trial of intravenous N‐acetylcysteine to prevent contrast induced nephropathy in acute coronary syndromes , 2012, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[126]  R. Schein,et al.  Risk of contrast induced nephropathy in the critically ill: a prospective, case matched study , 2012, Critical Care.

[127]  A. Oguzhan,et al.  Does Nebivolol Prevent Contrast‐Induced Nephropathy in Humans? , 2012, Clinical cardiology.

[128]  U. Erkorkmaz,et al.  Intravenous N-acetylcysteine plus high-dose hydration versus high-dose hydration and standard hydration for the prevention of contrast-induced nephropathy: CASIS--a multicenter prospective controlled trial. , 2012, International journal of cardiology.

[129]  H. Shemirani,et al.  A randomized trial of saline hydration to prevent contrast-induced nephropathy in patients on regular captopril or furosemide therapy undergoing percutaneous coronary intervention. , 2012, Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia.

[130]  C. Schindler,et al.  Sodium chloride vs. sodium bicarbonate for the prevention of contrast medium-induced nephropathy: a randomized controlled trial. , 2012, European heart journal.

[131]  Takeshi Nakaura,et al.  Abdominal dynamic CT in patients with renal dysfunction: contrast agent dose reduction with low tube voltage and high tube current-time product settings at 256-detector row CT. , 2011, Radiology.

[132]  J. Yee,et al.  Persistent renal enhancement after intra-arterial versus intravenous iodixanol administration. , 2011, European Journal of Radiology.

[133]  M. Leoncini,et al.  Effects of Hydration in Contrast-Induced Acute Kidney Injury After Primary Angioplasty: A Randomized, Controlled Trial , 2011, Circulation. Cardiovascular interventions.

[134]  Act Investigators.  Acetylcysteine for Prevention of Renal Outcomes in Patients Undergoing Coronary and Peripheral Vascular Angiography: Main Results From the Randomized Acetylcysteine for Contrast-Induced Nephropathy Trial (ACT) , 2011, Circulation.

[135]  S. Banerjee,et al.  Effect of hydration with or without n-acetylcysteine on contrast induced nephropathy in patients undergoing coronary angiography and percutaneous coronary intervention. , 2011, Mymensingh medical journal : MMJ.

[136]  R. Karlsberg,et al.  Contrast medium-induced acute kidney injury: comparison of intravenous and intraarterial administration of iodinated contrast medium. , 2011, Journal of vascular and interventional radiology : JVIR.

[137]  G. Cho,et al.  Comparison of contrast-induced nephrotoxicity of iodixanol and iopromide in patients with renal insufficiency undergoing coronary angiography. , 2011, The American journal of cardiology.

[138]  V. Pasceri,et al.  Short-term, high-dose Atorvastatin pretreatment to prevent contrast-induced nephropathy in patients with acute coronary syndromes undergoing percutaneous coronary intervention (from the ARMYDA-CIN [atorvastatin for reduction of myocardial damage during angioplasty--contrast-induced nephropathy] tria , 2011, The American journal of cardiology.

[139]  F. Brunelle,et al.  Renal safety in pediatric imaging: randomized, double-blind phase IV clinical trial of iobitridol 300 versus iodixanol 270 in multidetector CT , 2011, Pediatric Radiology.

[140]  G. Schuler,et al.  Impact of N-acetylcysteine on contrast-induced nephropathy defined by cystatin C in patients with ST-elevation myocardial infarction undergoing primary angioplasty , 2011, Clinical Research in Cardiology.

[141]  T. Iwasaka,et al.  A new protocol using sodium bicarbonate for the prevention of contrast-induced nephropathy in patients undergoing coronary angiography. , 2011, The American journal of cardiology.

[142]  I. Seong,et al.  Preventive strategies of renal insufficiency in patients with diabetes undergoing intervention or arteriography (the PREVENT Trial). , 2011, The American journal of cardiology.

[143]  P. Serruys,et al.  Frequency, determinants, and prognostic effects of acute kidney injury and red blood cell transfusion in patients undergoing transcatheter aortic valve implantation , 2011, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[144]  J. Manitius,et al.  High incidence of nephropathy in neurosurgical patients after intra-arterial administration of low-osmolar and iso-osmolar contrast media , 2011, Acta radiologica.

[145]  I. Komuro,et al.  Prevention of contrast-induced nephropathy by bolus injection of sodium bicarbonate in patients with chronic kidney disease undergoing emergent coronary procedures. , 2011, The American journal of cardiology.

[146]  J. Gillard,et al.  Does Oral N-Acetylcysteine Reduce Contrast-Induced Renal Injury in Patients With Peripheral Arterial Disease Undergoing Peripheral Angiography? A Randomized-Controlled Study , 2011, Angiology.

[147]  H. Frankel,et al.  Posttraumatic contrast-induced acute kidney injury: minimal consequences or significant threat? , 2011, The Journal of trauma.

[148]  G. Breithardt,et al.  Prognostic Value of Different Laboratory Measures of Renal Function for Long‐Term Mortality After Contrast Media‐Associated Renal Impairment , 2010, Clinical cardiology.

[149]  K. Poh,et al.  Comparison of risks and clinical predictors of contrast-induced nephropathy in patients undergoing emergency versus nonemergency percutaneous coronary interventions. , 2010, Journal of interventional cardiology.

[150]  H. Trivedi,et al.  Hydration with sodium bicarbonate for the prevention of contrast-induced nephropathy: a meta-analysis of randomized controlled trials. , 2010, Clinical nephrology.

[151]  W. Wróbel,et al.  Oral versus intravenous hydration and renal function in diabetic patients undergoing percutaneous coronary interventions. , 2010, Kardiologia polska.

[152]  Jeremiah R. Brown,et al.  Does Safe Dosing of Iodinated Contrast Prevent Contrast-Induced Acute Kidney Injury? , 2010, Circulation. Cardiovascular interventions.

[153]  O. Djurdjev,et al.  Chronic kidney injury in patients after cardiac catheterisation or percutaneous coronary intervention: a comparison of radial and femoral approaches (from the British Columbia Cardiac and Renal Registries) , 2010, Heart.

[154]  W. Foley,et al.  Contrast-induced nephropathy after a second contrast exposure , 2010, Renal failure.

[155]  J. Newhouse,et al.  Intravenous contrast medium-induced nephrotoxicity: is the medical risk really as great as we have come to believe? , 2010, Radiology.

[156]  G. La Manna,et al.  Risk for contrast nephropathy in patients undergoing coronarography. , 2010, Artificial organs.

[157]  K. Furie,et al.  Functional Contrast-Enhanced CT for Evaluation of Acute Ischemic Stroke Does Not Increase the Risk of Contrast-Induced Nephropathy , 2010, American Journal of Neuroradiology.

[158]  K. Poh,et al.  Risk factors and clinical outcomes for contrast-induced nephropathy after percutaneous coronary intervention in patients with normal serum creatinine. , 2010, Annals of the Academy of Medicine, Singapore.

[159]  G. Breithardt,et al.  Impact of renin-angiotensin-aldosterone blockade by angiotensin-converting enzyme inhibitors or AT-1 blockers on frequency of contrast medium-induced nephropathy: a post-hoc analysis from the Dialysis-versus-Diuresis (DVD) trial. , 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[160]  T. Iwasaka,et al.  Contrast-induced nephropathy in patients undergoing emergency percutaneous coronary intervention for acute coronary syndrome. , 2010, The American journal of cardiology.

[161]  M. Mansournia,et al.  Sodium bicarbonate in preventing contrast nephropathy in patients at risk for volume overload: a randomized controlled trial. , 2010, Journal of nephrology.

[162]  I. Malik,et al.  Metformin: safety in cardiac patients , 2010, Postgraduate Medical Journal.

[163]  Philippe Pibarot,et al.  Acute kidney injury following transcatheter aortic valve implantation: predictive factors, prognostic value, and comparison with surgical aortic valve replacement , 2009, European heart journal.

[164]  I. Slotki,et al.  Sodium bicarbonate versus sodium chloride and oral N-acetylcysteine for the prevention of contrast-induced nephropathy in advanced chronic kidney disease. , 2009, Journal of interventional cardiology.

[165]  M. Velázquez,et al.  Comparison of iodixanol and ioversol for the prevention of contrast-induced nephropathy in diabetic patients after coronary angiography or angioplasty. , 2009, Revista espanola de cardiologia.

[166]  M. Jardine,et al.  Systematic Review: Sodium Bicarbonate Treatment Regimens for the Prevention of Contrast-Induced Nephropathy , 2009, Annals of Internal Medicine.

[167]  Charles Davidson,et al.  Nephrotoxicity of iodixanol versus iopamidol in patients with chronic kidney disease and diabetes mellitus undergoing coronary angiographic procedures. , 2009, American heart journal.

[168]  A. Rashid,et al.  Incidence of Contrast-induced Nephropathy in Intensive Care Patients Undergoing Computerised Tomography and Prevalence of Risk Factors , 2009, Anaesthesia and intensive care.

[169]  G. Dangas,et al.  Sodium bicarbonate for the prevention of contrast induced-acute kidney injury: a systematic review and meta-analysis. , 2009, Clinical journal of the American Society of Nephrology : CJASN.

[170]  Toru Watanabe,et al.  Efficacy of single-bolus administration of sodium bicarbonate to prevent contrast-induced nephropathy in patients with mild renal insufficiency undergoing an elective coronary procedure. , 2009, The American journal of cardiology.

[171]  M. Mansournia,et al.  Sodium bicarbonate plus isotonic saline versus saline for prevention of contrast-induced nephropathy in patients undergoing coronary angiography: a randomized controlled trial. , 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[172]  A. Kastrati,et al.  Choice of Contrast Medium in Patients With Impaired Renal Function Undergoing Percutaneous Coronary Intervention , 2009, Circulation. Cardiovascular interventions.

[173]  S. Majumdar,et al.  Forced euvolemic diuresis with mannitol and furosemide for prevention of contrast-induced nephropathy in patients with CKD undergoing coronary angiography: a randomized controlled trial. , 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[174]  Jonathan Himmelfarb,et al.  Fluid accumulation, survival and recovery of kidney function in critically ill patients with acute kidney injury. , 2009, Kidney international.

[175]  Takeshi Kimura,et al.  Incidence of and risk factors for contrast-induced nephropathy after cardiac catheterization in Japanese patients. , 2009, Circulation journal : official journal of the Japanese Circulation Society.

[176]  Eric E. Smith,et al.  CT Angiography for Intracerebral Hemorrhage Does Not Increase Risk of Acute Nephropathy , 2009, Stroke.

[177]  H. Gurm,et al.  Sodium bicarbonate-based hydration prevents contrast-induced nephropathy: a meta-analysis , 2009, BMC medicine.

[178]  P. Teirstein,et al.  Ionic low-osmolar versus nonionic iso-osmolar contrast media to obviate worsening nephropathy after angioplasty in chronic renal failure patients: the ICON (Ionic versus non-ionic Contrast to Obviate worsening Nephropathy after angioplasty in chronic renal failure patients) study. , 2009, JACC. Cardiovascular interventions.

[179]  F. Turgut,et al.  Sodium bicarbonate for the prevention of contrast-induced nephropathy: a meta-analysis of 17 randomized trials , 2009, International Urology and Nephrology.

[180]  M. Gee,et al.  In emergency situations, should serum creatinine be checked in all patients before performing second contrast CT examinations within 24 hours? , 2009, Journal of the American College of Radiology : JACR.

[181]  Sonal Singh,et al.  Sodium bicarbonate therapy for prevention of contrast-induced nephropathy: a systematic review and meta-analysis. , 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[182]  K. Okumura,et al.  Renal protective effects and the prevention of contrast-induced nephropathy by atrial natriuretic peptide. , 2009, Journal of the American College of Cardiology.

[183]  F. Scolari,et al.  Atheroembolic renal disease , 2009, The Lancet.

[184]  Young‐Bae Park,et al.  N-acetylcysteine versus AScorbic acid for preventing contrast-Induced nephropathy in patients with renal insufficiency undergoing coronary angiography NASPI study-a prospective randomized controlled trial. , 2009, American heart journal.

[185]  F. Veglia,et al.  Contrast Volume During Primary Percutaneous Coronary Intervention and Subsequent Contrast-Induced Nephropathy and Mortality , 2009, Annals of Internal Medicine.

[186]  S. Navaneethan,et al.  Atrial natriuretic peptide for management of acute kidney injury: a systematic review and meta-analysis. , 2009, Clinical journal of the American Society of Nephrology : CJASN.

[187]  Kuender D Yang,et al.  Comparison of Iodixanol and Iohexol in Patients Undergoing Intravenous Pyelography: A Prospective Controlled Study , 2009, Renal failure.

[188]  D. Leung,et al.  Nephrotoxic effects of iodixanol and iopromide in patients with abnormal renal function receiving N‐acetylcysteine and hydration before coronary angiography and intervention: a randomized trial , 2009, Internal medicine journal.

[189]  Yu-jie Zhou,et al.  A prospective, double‐blind, randomized, controlled trial on the efficacy and cardiorenal safety of iodixanol vs. iopromide in patients with chronic kidney disease undergoing coronary angiography with or without percutaneous coronary intervention , 2008, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[190]  D. Gladstone,et al.  Renal Safety of CT Angiography and Perfusion Imaging in the Emergency Evaluation of Acute Stroke , 2008, American Journal of Neuroradiology.

[191]  Furman S. McDonald,et al.  Mortality associated with nephropathy after radiographic contrast exposure. , 2008, Mayo Clinic proceedings.

[192]  W. Laskey,et al.  Nephrotoxicity of iodixanol versus ioversol in patients with chronic kidney disease: the Visipaque Angiography/Interventions with Laboratory Outcomes in Renal Insufficiency (VALOR) Trial. , 2008, American heart journal.

[193]  A. Shah,et al.  Sodium bicarbonate vs sodium chloride for the prevention of contrast medium-induced nephropathy in patients undergoing coronary angiography: a randomized trial. , 2008, JAMA.

[194]  F. Mach,et al.  Renin-angiotensin system blockade and contrast-induced renal toxicity. , 2008, Journal of nephrology.

[195]  M. Fine,et al.  Incidence and outcomes of contrast-induced AKI following computed tomography. , 2008, Clinical journal of the American Society of Nephrology : CJASN.

[196]  N. Hosten,et al.  No Increased Risk for Contrast-Induced Nephropathy after Multiple CT Perfusion Studies of the Brain with a Nonionic, Dimeric, Iso-Osmolal Contrast Medium , 2008, American Journal of Neuroradiology.

[197]  H. Gurm,et al.  Current role of sodium bicarbonate-based preprocedural hydration for the prevention of contrast-induced acute kidney injury: a meta-analysis. , 2008, American heart journal.

[198]  R. Solomon.  Contrast-induced acute kidney injury: is there a risk after intravenous contrast? , 2008, Clinical journal of the American Society of Nephrology : CJASN.

[199]  V. Guetta,et al.  Reversible Acute Kidney Injury following Contrast Exposure and the Risk of Long-Term Mortality , 2008, American Journal of Nephrology.

[200]  M. Leoncini,et al.  Sodium bicarbonate versus saline for the prevention of contrast-induced nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention. , 2008, Journal of the American College of Cardiology.

[201]  B. Jaber,et al.  Timing of renal replacement therapy initiation in acute renal failure: a meta-analysis. , 2008, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[202]  David Y. Kho,et al.  Frequency of serum creatinine changes in the absence of iodinated contrast material: implications for studies of contrast nephrotoxicity. , 2008, AJR. American journal of roentgenology.

[203]  U. Schoepf,et al.  Iso-osmolality versus low-osmolality iodinated contrast medium at intravenous contrast-enhanced CT: effect on kidney function. , 2008, Radiology.

[204]  P. Aspelin,et al.  Contrast medium dose-to-gfr ratio: a measure of systemic exposure to predict contrast-induced nephropathy after percutaneous coronary intervention , 2008, Acta radiologica.

[205]  E. V. van Beek,et al.  The PREDICT study: a randomized double-blind comparison of contrast-induced nephropathy after low- or isoosmolar contrast agent exposure. , 2008, AJR. American journal of roentgenology.

[206]  Didier Payen,et al.  A positive fluid balance is associated with a worse outcome in patients with acute renal failure , 2008, Critical care.

[207]  R. Robbs,et al.  Renal effects of contrast media in diabetic patients undergoing diagnostic or interventional coronary angiography. , 2008, Journal of diabetes and its complications.

[208]  M. Devita,et al.  The effect of withdrawal of ACE inhibitors or angiotensin receptor blockers prior to coronary angiography on the incidence of contrast-induced nephropathy , 2008, International Urology and Nephrology.

[209]  Jeffrey M Schussler,et al.  Contrast-induced acute kidney injury. , 2018, Journal of the American College of Cardiology.

[210]  Yong-Jin Kim,et al.  Prevention of radiocontrast medium-induced nephropathy using short-term high-dose simvastatin in patients with renal insufficiency undergoing coronary angiography (PROMISS) trial--a randomized controlled study. , 2008, American heart journal.

[211]  H. Thomsen,et al.  The ACTIVE Trial: Comparison of the Effects on Renal Function of Iomeprol-400 and Iodixanol-320 in Patients With Chronic Kidney Disease Undergoing Abdominal Computed Tomography , 2008, Investigative radiology.

[212]  Deepak Sharma,et al.  Metformin-associated lactic acidosis following contrast media-induced nephrotoxicity. , 2008, European journal of anaesthesiology.

[213]  Omer Toprak.  Conflicting and new risk factors for contrast induced nephropathy. , 2007, The Journal of urology.

[214]  K. Reynen,et al.  Failure of ascorbic acid to prevent contrast-media induced nephropathy in patients with renal dysfunction. , 2007, Clinical nephrology.

[215]  W. Laskey,et al.  Volume-to-creatinine clearance ratio: a pharmacokinetically based risk factor for prediction of early creatinine increase after percutaneous coronary intervention. , 2007, Journal of the American College of Cardiology.

[216]  Samin K. Sharma,et al.  Cardiac Angiography in Renally Impaired Patients (CARE) Study: A Randomized Double-Blind Trial of Contrast-Induced Nephropathy in Patients With Chronic Kidney Disease , 2007, Circulation.

[217]  J. Kaski,et al.  The reno-protective effect of hydration with sodium bicarbonate plus N-acetylcysteine in patients undergoing emergency percutaneous coronary intervention: the RENO Study. , 2007, Journal of the American College of Cardiology.

[218]  A. Colombo,et al.  Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): A Randomized Comparison of 3 Preventive Strategies , 2007, Circulation.

[219]  Gilles Soulez,et al.  Contrast-Induced Nephropathy in Patients With Chronic Kidney Disease Undergoing Computed Tomography: A Double-Blind Comparison of Iodixanol and Iopamidol , 2006, Investigative radiology.

[220]  R. Erbel,et al.  Nephrotoxicity of iso-osmolar versus low-osmolar contrast media is equal in low risk patients. , 2006, Clinical nephrology.

[221]  J. Brophy,et al.  Association of selective and conventional nonsteroidal antiinflammatory drugs with acute renal failure: A population-based, nested case-control analysis. , 2006, American journal of epidemiology.

[222]  Young‐Bae Park,et al.  Renal toxicity evaluation and comparison between visipaque (iodixanol) and hexabrix (ioxaglate) in patients with renal insufficiency undergoing coronary angiography: the RECOVER study: a randomized controlled trial. , 2006, Journal of the American College of Cardiology.

[223]  J. Brinker,et al.  A meta-analysis of the renal safety of isosmolar iodixanol compared with low-osmolar contrast media. , 2006, Journal of the American College of Cardiology.

[224]  P. Auquier,et al.  A randomized trial of saline hydration to prevent contrast nephropathy in chronic renal failure patients. , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[225]  W. Hörl,et al.  Effect of radio contrast media on residual renal function in peritoneal dialysis patients--a prospective study. , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[226]  K. Eckardt,et al.  'Low-dose' dopamine worsens renal perfusion in patients with acute renal failure. , 2006, Kidney international.

[227]  O. Moranne,et al.  Effect of iodinated contrast agents on residual renal function in PD patients. , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[228]  R. Mehran,et al.  Contrast-induced nephropathy: definition, epidemiology, and patients at risk. , 2006, Kidney international. Supplement.

[229]  P. Parfrey,et al.  Preventing Nephropathy Induced by Contrast Medium , 2006 .

[230]  P. Aspelin,et al.  Contrast-medium-induced nephropathy correlated to the ratio between dose in gram iodine and estimated gfr in ml/min , 2005, Acta radiologica.

[231]  M. Stumvoll,et al.  Contraindications can damage your health—is metformin a case in point? , 2005, Diabetologia.

[232]  Joseph Beyene,et al.  Meta-Analysis: Low-Dose Dopamine Increases Urine Output but Does Not Prevent Renal Dysfunction or Death , 2005, Annals of Internal Medicine.

[233]  F. Veglia,et al.  Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction. , 2004, Journal of the American College of Cardiology.

[234]  G. Stone,et al.  Impact of chronic kidney disease on prognosis of patients with diabetes mellitus treated with percutaneous coronary intervention. , 2004, The American journal of cardiology.

[235]  T. Risler,et al.  What is the best hydration regimen to prevent contrast media-induced nephrotoxicity? , 2004, Clinical nephrology.

[236]  S. Ricksten,et al.  Recombinant human atrial natriuretic peptide in ischemic acute renal failure: A randomized placebo-controlled trial* , 2004, Critical care medicine.

[237]  F. Holleman,et al.  Metformin and lactic acidosis: cause or coincidence? A review of case reports , 2004, Journal of internal medicine.

[238]  J. J. Griffin,et al.  Impact of Renal Insufficiency in Patients Undergoing Primary Angioplasty for Acute Myocardial Infarction , 2003, Circulation.

[239]  Christopher M. Thompson,et al.  Optimal timing of hydration to erase contrast-associated nephropathy: the OTHER CAN study. , 2003, The Journal of invasive cardiology.

[240]  T. Nakano,et al.  Cholesterol crystal embolization (CCE) after cardiac catheterization: a case report and a review of 36 cases in the Japanese literature. , 2003, Japanese heart journal.

[241]  A. Takeshita,et al.  The incidence and risk factors of cholesterol embolization syndrome, a complication of cardiac catheterization: a prospective study , 2003 .

[242]  G. Stone,et al.  A risk score for prediction of contrast induced nephropathy after percutaneous coronary intervention , 2003 .

[243]  A. Agrawal,et al.  A Randomized Prospective Trial to Assess the Role of Saline Hydration on the Development of Contrast Nephrotoxicity , 2003, Nephron Clinical Practice.

[244]  M. Galanski,et al.  Contrast media nephropathy: intravenous CT angiography versus intraarterial digital subtraction angiography in renal artery stenosis: a prospective randomized trial. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[245]  Kirk N. Garratt,et al.  Incidence and Prognostic Importance of Acute Renal Failure After Percutaneous Coronary Intervention , 2002, Circulation.

[246]  S. Marsch,et al.  Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. , 2002, Archives of internal medicine.

[247]  R. Bellomo,et al.  Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial , 2000, The Lancet.

[248]  G. Dangas,et al.  The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency. , 2000, Journal of the American College of Cardiology.

[249]  N. Chalmers,et al.  Comparison of iodixanol and iohexol in renal impairment. , 1999, The British journal of radiology.

[250]  M. Leon,et al.  Effects of dopamine and aminophylline on contrast-induced acute renal failure after coronary angioplasty in patients with preexisting renal insufficiency. , 1999, The American journal of cardiology.

[251]  Allen J. Taylor,et al.  Clinical InvestigationsCardiologyPREPARED: PREParation for Angiography in REnal Dysfunction: A Randomized Trial of Inpatient vs Outpatient Hydration Protocols for Cardiac Catheterization in Mild-to-Moderate Renal Dysfunction , 1998 .

[252]  P. Rasuli,et al.  Metformin and contrast media: where is the conflict? , 1998, Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes.

[253]  W. O’Neill,et al.  Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. , 1997, The American journal of medicine.

[254]  R. Lafayette,et al.  Anaritide in Acute Tubular Necrosis , 1997 .

[255]  J. D'Elia,et al.  Effects of saline, mannitol, and furosemide on acute decreases in renal function induced by radiocontrast agents. , 1994, The New England journal of medicine.

[256]  J. Kaude,et al.  Dialysis is not indicated immediately after administration of nonionic contrast agents in patients with end-stage renal disease treated by maintenance dialysis. , 1994, AJR. American journal of roentgenology.

[257]  P. Parfrey,et al.  Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. A prospective controlled study. , 1989, The New England journal of medicine.

[258]  A. Gomes,et al.  Acute renal dysfunction after major arteriography. , 1985, AJR. American journal of roentgenology.

[259]  W. Bank,et al.  Renal failure after major angiography can be avoided with hydration. , 1981, AJR. American journal of roentgenology.

[260]  Jennifer L. Boxen,et al.  Acute Kidney Injury After Computed Tomography: A Meta‐analysis , 2018, Annals of emergency medicine.

[261]  A. Demchuk,et al.  Neurons Over Nephrons: Systematic Review and Meta-Analysis of Contrast-Induced Nephropathy in Patients With Acute Stroke , 2017, Stroke.

[262]  D. Kallmes,et al.  Is the Presence of a Solitary Kidney an Independent Risk Factor for Acute Kidney Injury after Contrast-enhanced CT? , 2016, Radiology.

[263]  A. Hillis,et al.  N-acetylcysteine and/or ascorbic acid versus placebo to prevent contrast-induced nephropathy in patients undergoing elective cardiac catheterization: The NAPCIN trial; A single-center, prospective, randomized trial. , 2016, Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia.

[264]  P. Leprince,et al.  Impact of chronic kidney disease on the outcomes of transcatheter aortic valve implantation: results from the FRANCE 2 registry. , 2015, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[265]  Y. Yamashita,et al.  Low contrast and radiation dose coronary CT angiography using a 320-row system and a refined contrast injection and timing method. , 2015, Journal of cardiovascular computed tomography.

[266]  Margaret J. Wong,et al.  Risk of contrast-induced nephropathy for patients receiving intravenous vs. intra-arterial iodixanol administration , 2015, Abdominal Radiology.

[267]  Michael E Matheny,et al.  Contemporary incidence, predictors, and outcomes of acute kidney injury in patients undergoing percutaneous coronary interventions: insights from the NCDR Cath-PCI registry. , 2014, JACC. Cardiovascular interventions.

[268]  A. Sato,et al.  Clinical predictors of contrast-induced acute kidney injury in patients undergoing emergency versus elective percutaneous coronary intervention. , 2014, Circulation journal : official journal of the Japanese Circulation Society.

[269]  A. Picchi,et al.  Impact of iso-osmolar versus low-osmolar contrast agents on contrast-induced nephropathy and tissue reperfusion in unselected patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention (from the Contrast Media and Nephrotoxicity Following Primary A , 2012, The American journal of cardiology.

[270]  Norbert Lameire,et al.  Notice , 2012, Kidney International Supplements.

[271]  C. Ronco,et al.  Renal replacement therapies for prevention of radiocontrast-induced nephropathy: a systematic review. , 2012, The American journal of medicine.

[272]  J. Leipsic,et al.  Reduced iodine load at CT pulmonary angiography with dual-energy monochromatic imaging: comparison with standard CT pulmonary angiography--a prospective randomized trial. , 2012, Radiology.

[273]  Mu‐Shun Huang,et al.  N-acetylcysteine for the prevention of contrast-induced nephropathy in the emergency department. , 2012, Internal medicine.

[274]  Toshihisa Hirai,et al.  Does N-acetylcysteine reduce the incidence of contrast-induced nephropathy and clinical events in patients undergoing primary angioplasty for acute myocardial infarction? , 2011, Internal medicine.

[275]  S. Goergen,et al.  Systematic review of current guidelines, and their evidence base, on risk of lactic acidosis after administration of contrast medium for patients receiving metformin. , 2010, Radiology.

[276]  M. Joannidis,et al.  Prevention of contrast media-induced nephropathy by isotonic sodium bicarbonate: a meta-analysis , 2008, Wiener klinische Wochenschrift.

[277]  G. Stone,et al.  Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables. , 2005, The American journal of cardiology.

[278]  F. Gilbert,et al.  Metformin and contrast media--a dangerous combination? , 1999, Clinical Radiology.

[279]  H. S. Thomsen,et al.  Contrast-media-induced nephrotoxicity: a consensus report , 1999, European Radiology.

[280]  M. Cova,et al.  Effects of a dimeric vs a monomeric nonionic contrast medium on renal function in patients with mild to moderate renal insufficiency: a double-blind, randomized clinical trial , 1998, European Radiology.

[281]  M. Popovtzer,et al.  Metformin-lnduced Lactic Acidosis Associated with Acute Renal Failure , 1996 .

[282]  W. Bank,et al.  Renal failure after major angiography. , 1980, The American journal of medicine.